Patents by Inventor Nancy Denève

Nancy Denève has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TARGETING OF ALPHA-1 OR ALPHA-3 SUBUNIT OF NA+, K+-ATPASE IN THE TREATMENT OF PROLIFERATIVE DISEASES
    Publication number: 20100068198
    Abstract: Targeting of select subunits of the Na+,K+-ATPase is described, and especially the alpha-1 subunit and/or the alpha-3 subunit. Antisense agents, agents capable of causing RNA interference that can reduce the expression of Na+,K+-ATPase, and antibodies and antibody fragments and derivatives specific for Na+,K+-ATPase are useful as reagents and pharmaceutical formulations for the treatment of proliferative diseases, such as tumours and cancers. Methods and kits are also described.
    Type: Application
    Filed: November 9, 2006
    Publication date: March 18, 2010
    Applicant: Unibioscreen S.A.
    Inventors: Tatjana Mijatovic, Eric Van Quaquebeke, Nancy Denève, Laurent Van den Hove, Francis Darro, Robert Kiss